Corcept Therapeutics

Cushing's Patient Advocate

Corcept Therapeutics  •  $145k - $181k/yr  •  Remote  •  15 days ago
Expired
AI can make mistakes so check important info. Chat history is never stored.

Job Description

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.

Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.

Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com

The Patient Advocate will provide support and education to Korlym patients who have opted in to our program. You will closely collaborate with our internal teams and specialty pharmacy as part of Corcept’s dedication to excellence within our patient-centered approach.

Responsibilities:

  • Establish relationships with patients with Cushing’s Syndrome who are being treated with Korlym to provide information and disease state education. Refer patients to HCP or specialty pharmacy when medical advice is needed or requested 
  • Work closely with internal teams and specialty pharmacy to ensure excellent patient support 
  • Document patient case notes and follow procedures around protecting PHI and document retention 
  • Report product adverse events to Corcept medical information hotline 
  • Maintain the highest standards of scientific, clinical, and technical expertise in Cushing’s Syndrome

Preferred Skills, Qualifications and Technical Proficiencies:

  • A positive, compassionate, caring attitude for patients suffering from a rare disease 
  • Good listener with the ability to communicate scientific and medical information clearly 
  • Ability to connect with a diverse group of individuals and develop rapport quickly 
  • Ability to work both independently and collaboratively within a dynamic team setting 
  • Ability to consistently and accurately document pertinent information in a secure database; proficient with reporting 
  • Occasional travel required 
  • Candidates located in the Central Time Zone are preferred 

Preferred Education and Experience:

  • Direct patient support experience in a medical setting required, including backgrounds such as nurse, diabetes educator or pharmacist
  • Experience working in patient support in the pharmaceutical industry is strongly desired.  Experience in endocrinology is a bonus
  • 4-year degree required 

The pay range that the Company reasonably expects to pay for this position is $144,700 - $180,900; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

Applicants must be currently authorized to work in the United States on a full-time basis.

For information on how Corcept collects, uses, discloses, protects, and otherwise processes personal information and an explanation of the rights and choices available to you with respect to your personal information, please refer to our Privacy Notice link

Corcept appreciates the commitment and hard work of all our team members as we strive to discover and develop novel treatments for patients with serious unmet medical needs.

Please visit our website at: https://www.corcept.com/

Corcept is an Equal Opportunity Employer

Corcept will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third-party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Corcept.

Corcept Therapeutics

About Corcept Therapeutics

We’ve been unlocking the potential of cortisol modulation for more than 25 years.

We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

Industry
Biotech & Life Sciences
Company Size
501-1,000 employees
Headquarters
Redwood City, California
Year Founded
1998
Social Media